查詢結果分析
來源資料
相關文獻
- 小柴胡湯、加味逍遙散與茵陳五苓散對肝硬化的療效:藉都卜勒超音波術觀察
- 以彩色都卜勒超音波評估肝硬化與門脈高壓
- 利用都卜勒超音波測量肝硬化及肝癌患者之肝門靜脈血流量
- Portal Vein Velocity by Duplex Doppler Ultransound as an Indication of the Clinical Severity of Portal Hypertension
- Pulmonary Function Changes in Cirrhotic Patients
- In Vitro Assessment of the Flow Fields in a Three-Dimensional Pulmonary Artery Model with Varying Degrees of Valvular Stenosis
- Recurrent Spontaneous Bacterial Empyema in Cirrhosis: A Case Report
- Congenital Renal Arteriovenous Malformation--3 Cases Report
- 肝硬化患者之細菌性感染--157位病例研究
- Isolated Fundic Varices in Liver Cirrhosis
頁籤選單縮合
題名 | 小柴胡湯、加味逍遙散與茵陳五苓散對肝硬化的療效:藉都卜勒超音波術觀察= |
---|---|
作者 | 吳重慶; |
期刊 | 中醫藥年報 |
出版日期 | 19970500 |
卷期 | 15:1 1997.05[民86.05] |
頁次 | 頁529-541 |
分類號 | 414.5 |
語文 | chi |
關鍵詞 | 肝硬化; 加味逍遙散; 門脈高壓指數; 肝硬化指數; 都卜勒超音波; Liver cirrhosis; Jia-wey-shiau-yau-saan; PVH index; LCI; Color doppler ultrasound; |
中文摘要 | 自 1994年8月 至1996年8月 間 , 針對Hep-Forte/Hepaticure (民間所謂的"保 肝片 " ) 及加味逍遙散 (普遍流行於民間的漢方 ) 的投予,來觀察治療慢性肝病患者的成 效。 發現: Hepa-Forte/ Hepaticure (HF/HP) 1# BID 的投予, 患者肝細胞壞死指標 (SGOT/ SGPT) 和肝硬化指數 (Liver Cirrhosis Index, LCI) 均呈惡化現象 (治療前後的 差異, 分別、為 p<0.0l,p<0.05 和 p<0.001 ); 若加上加味逍遙散 (KH ) 3.0Gm BID 的 投予,則呈現療效,而肝細胞壞死指標、肝硬化指數和門脈高壓指數 (PVH index ) 均有明 顯改善現象 (p 分別為 p<0.05,p<0.0l,p<0.00l p<0.05 )。 本研究顯示: 合併使用中西 藥 (HF/HP+KH) 的投予,對於慢性肝病過程,可能極有穩定的作用。 |
英文摘要 | In order to understand the effect of certain Chinese Herb in the treatment of chronic liver disease, esp. liver cirrhosis, an abservation through comparison of therapeutic effects of HF/ HP (Hep-Forte 1# BID+eHepaticure 1# BID) and combination of HF/ HP and KH(Jia-Wey-Shiau-Yau- Saan 3.0Gm BID) was performed from Aug. 1994 to Aug. 1996. The result revealed that HF/HP did not improve the illness, but HF/HP+KH did. HF/HP let SGOT/SGPT elevated (before-R vs after-R:from 63.7 ± 39.6 u/l to 97.7 ± 62.1 u/l and from 97.3 u/l to 162.0 ± 145.7 u/l, respectively; p<0.01 and p<0.05), and LCI(Liver Cirrhosis Index by color Doppler ultrasound) elevated(from 1.24 ± 0.41 to 1.49 ± 0.76 p<0.001). Combination of HF/HP+KH let SGOT/SGPT decreased(from 102.9 ± 83.1 u/l to 46.2 ± 23.0 u/l and from 188.9 ± 196.3 u/l to 62.1 ± 43.5 respectively: p<0.05 and p<0.01) LCI decreased(from 1.46 ± 0.64 to 1.18 ± 0.41, p<0.05) and PVH index(from 0.53 ± 0.11 to 0.4 ± 0.09, p<0.001). The conclusion is that combination of Hep-Forte/Hepaticure and Jia-Wey-Shiau-Yau-San 3.OGm BID may have some benefits in the control of chronic liver disease, esp. liver cirrhosis. |
本系統之摘要資訊系依該期刊論文摘要之資訊為主。